Daria Korneva
Nurse Practitioner · Bayonne, NJNPI 1609532183
Payments from drug & device makers
Across 235 payments — averaging $21.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$941
- Boehringer Ingelheim$703
- AstraZeneca$659
- Novo Nordisk$416
- Dexcom, Inc.$386
- Amgen$304
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,98498%
- Education$120%
- Gifts$591%
- Other$200%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 61 | $941 |
| Boehringer Ingelheim | 10 | $703 |
| AstraZeneca | 34 | $659 |
| Novo Nordisk | 25 | $416 |
| Dexcom, Inc. | 4 | $386 |
| Amgen | 14 | $304 |
| Corcept Therapeutics | 11 | $200 |
| Mannkind Corporation | 9 | $185 |
| Xeris Pharmaceuticals, Inc. | 10 | $167 |
| Medtronic | 4 | $143 |
| Sanofi-aventis U.S. LLC | 9 | $139 |
| Cequr Corporation | 3 | $123 |
| Insulet Corporation | 5 | $105 |
| Tandem Diabetes Care, Inc. | 3 | $73 |
| Bayer | 4 | $70 |
| Antares Pharma, Inc. | 3 | $53 |
| Tolmar, Inc. | 3 | $50 |
| Amphastar Pharmaceuticals, Inc. | 3 | $50 |
| Verity Pharmaceuticals Inc. | 2 | $31 |
| IBSA Pharma Inc. | 2 | $31 |
| BD | 2 | $30 |
| GSK | 2 | $28 |
| Abbott | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
| Dynavax Technologies Corporation | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Novartis | 1 | $15 |
| Embecta Corp. | 1 | $15 |
| Amryt Pharma Holdings Ltd | 1 | $14 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$620
- DEXCOM G6 TRANSMITTER$364
- MOUNJARO$125
- FARXIGA$122
- EVENITY$122
How this compares
$5,075 in reported general payments places this provider in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 341 | $546,905 |
| JardianceEmpagliflozin | 273 | $313,759 |
| FarxigaDapagliflozin Propanediol | 238 | $252,966 |
| TrulicityDulaglutide | 105 | $184,727 |
| MounjaroTirzepatide | 67 | $128,209 |
| JanuviaSitagliptin Phosphate | 73 | $56,635 |
| RybelsusSemaglutide | 28 | $53,151 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 63 | $47,126 |
| Tresiba Flextouch U-200Insulin Degludec | 22 | $28,343 |
| Tresiba Flextouch U-100Insulin Degludec | 41 | $26,930 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 61 | $24,835 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 14 | $23,401 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 81 | $23,300 |
| ProliaDenosumab | 13 | $22,682 |
| Humalog Kwikpen U-100Insulin Lispro | 60 | $21,550 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $416 | $604,698391 claims |
| Boehringer IngelheimJardiance, Synjardy | $703 | $328,508291 claims |
| Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro | $941 | $325,718234 claims |
| AstraZenecaFarxiga | $659 | $252,966238 claims |
| AmgenProlia | $304 | $22,68213 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $139 | $21,18916 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,138 nurse practitioner providers in New Jersey.
Other nurse practitioner in Bayonne
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
- Sophia KimEnglewood$70K
- Elizabeth FletcherCamden$62K
- Lannae EwingLinwood$39K
- Beth SavageNew Brunswick$34K
- Tina OcchiutoMorristown$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.